Glow Blend vs BPC-157
Side-by-side comparison of Glow Blend and BPC-157: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Glow Blend
BPC-157
Glow Blend
GHK-Cu + BPC-157 + TB-500 blend for skin and recovery
Lowest listed price: $99.99 across 3 listings
Full Glow Blend profileBPC-157
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a partial sequence of human gastric juice…
Lowest listed price: $34.99 across 15 listings
Full BPC-157 profileSide-by-side comparison
| Attribute | Glow Blend | BPC-157 |
|---|---|---|
| Category | Recovery | Injury, Repair & Recovery |
| Research Stage | Preclinical | Preclinical |
| Mechanism of Action | Glow Blend is a fixed combination of three research peptides, so its proposed effects are simply the sum of what each component does on its own - there is no unique "blend" mechanism, and no pharmacology study has ever been run on the three together. Each part… | Nitric Oxide (NO) System Modulation BPC-157 exerts a central integrative effect through modulation of the nitric oxide system. Studies by Seiwerth et al. (2022) demonstrated that BPC-157 counteracts both NO-excess and NO-deficiency states, functioning as a… |
| Half-Life | Varies by component - the blend has no single half-life. BPC-157 and the TB-500 (thymosin beta-4) fragment are small peptides cleared over hours; GHK-Cu is a short-lived tripeptide-copper complex. Community dosing frequency is driven by empirical practice, not by measured pharmacokinetics of the blend. | Short plasma half-life. The first formal preclinical ADME study reported an elimination half-life under ~30 minutes after IV/IM dosing in rats and dogs, with linear dose-proportional kinetics (PMID: 36588717); a 2026 biopharmaceutical review confirms this sub-30-minute plasma half-life and highlights a pharmacokinetic-pharmacodynamic disconnect, as biological effects persist for hours to days (PMID: 42198317). No full human pharmacokinetic study has been published; twice-daily dosing is empirical/community-standard rather than PK-derived. |
| Typical Dose Range | Blend - stated per component: GHK-Cu 1000-2000 mcg/day; BPC-157 250-500 mcg/dose; TB-500 2000-2500 mcg/dose. No validated dose exists for the combination (Research Use Only). | 200-500 mcg subcutaneous 1-2x daily (community protocols); 1-10 mcg/kg in animal studies |
| Dosing Frequency | GHK-Cu once daily; BPC-157 once to twice daily; TB-500 twice weekly during the loading phase, then every 1-2 weeks for maintenance. | Twice daily (AM and PM) for optimal serum levels; once daily acceptable |
| Administration | — | Subcutaneous, Oral, Intraperitoneal, Intravenous |
| Side Effects | Most reported effects are local: injection-site redness, swelling, itching, bruising or transient pain, plus mild skin sensitivity. GHK-Cu injections can sting, and with prolonged high-dose systemic use there is a theoretical concern for copper accumulation.… | Generally well-tolerated. Mild nausea or GI discomfort during initial use. Temporary increase in pain/inflammation at injury site (healing response). Rare: drowsiness, dizziness, mild headache. Very rare: transient changes in blood pressure. |
| Molecular Weight | — | 1419.5 g/mol (average); molecular formula C62H98N16O22 |
| Common Vial Sizes | — | 5mg, 10mg |
Price tracking
Price History
7 data points- OF
- BM
- Half Nattys
- LB
- Ion Peptide
- BHG Labs
Glow Blend: potential benefits
- Improved skin firmness and elasticity - GHK-Cu raised collagen and elastin and improved aged-skin firmness in controlled cosmetic studies [PMID:18644225]
- Reduced appearance of fine lines and photodamage (GHK-Cu cosmetic data) [PMID:18644225]
- Support for wound and connective-tissue repair - GHK-Cu and BPC-157 accelerated healing in animal models [PMID:8836453][PMID:30915550]
- Angiogenesis / improved local blood-vessel formation - a shared mechanism of BPC-157 and the thymosin beta-4 fragment in TB-500 [PMID:20388964][PMID:14500546]
- Faster recovery from tendon, ligament and muscle strain (BPC-157 preclinical data) [PMID:30915550]
- Anti-inflammatory and antioxidant support during recovery (GHK-Cu and thymosin beta-4) [PMID:18644225][PMID:27450738]
- Reported skin 'glow' and quicker soft-tissue recovery - community/anecdotal only, not clinically verified for the blend
BPC-157: potential benefits
- Accelerated tendon and ligament healing with improved biomechanical strength in preclinical soft-tissue injury models (PMID: 30915550)
- Gastric and GI mucosal cytoprotection against ethanol-induced lesions, mediated in part by the nitric oxide system (PMID: 30279308)
- Healing of cysteamine-induced colitis and colon anastomosis in preclinical inflammatory bowel disease models (PMID: 24304574)
- Neuroprotection with dopaminergic and nitric oxide-system modulation in central nervous system injury models such as stroke and dopamine-receptor blockade (PMID: 34380875)
- Promotion of angiogenesis via VEGFR2 up-regulation, internalization, and VEGFR2-Akt-eNOS signaling in rat hind-limb ischemia and endothelial assays (PMID: 27847966)
- Tendon fibroblast outgrowth, cell survival, and migration through FAK-paxillin pathway activation (PMID: 21030672)
- Growth hormone receptor up-regulation in tendon fibroblasts, potentiating growth hormone's proliferative effect (PMID: 25415472)
- Nitric oxide-system interaction with endothelium protection, angiogenesis, and EGR-1-mediated growth-factor and collagen expression (PMID: 22300085)
Frequently asked
What's the difference between Glow Blend and BPC-157?
Glow Blend is a recovery that glow blend is a fixed combination of three research peptides, so its proposed effects are simply the sum of what each component does on its own - there is no unique "blend"…. BPC-157 is a injury, repair & recovery that nitric oxide (no) system modulation bpc-157 exerts a central integrative effect through modulation of the nitric oxide system. studies by seiwerth et al. (2022) demonstrated that…. The two differ in mechanism, half-life (Varies by component - the blend has no single half-life. BPC-157 and the TB-500 (thymosin beta-4) fragment are small peptides cleared over hours; GHK-Cu is a short-lived tripeptide-copper complex. Community dosing frequency is driven by empirical practice, not by measured pharmacokinetics of the blend. vs Short plasma half-life. The first formal preclinical ADME study reported an elimination half-life under ~30 minutes after IV/IM dosing in rats and dogs, with linear dose-proportional kinetics (PMID: 36588717); a 2026 biopharmaceutical review confirms this sub-30-minute plasma half-life and highlights a pharmacokinetic-pharmacodynamic disconnect, as biological effects persist for hours to days (PMID: 42198317). No full human pharmacokinetic study has been published; twice-daily dosing is empirical/community-standard rather than PK-derived.), and typical dose range.
Which has the longer half-life, Glow Blend or BPC-157?
Glow Blend has a half-life of Varies by component - the blend has no single half-life. BPC-157 and the TB-500 (thymosin beta-4) fragment are small peptides cleared over hours; GHK-Cu is a short-lived tripeptide-copper complex. Community dosing frequency is driven by empirical practice, not by measured pharmacokinetics of the blend.. BPC-157 has a half-life of Short plasma half-life. The first formal preclinical ADME study reported an elimination half-life under ~30 minutes after IV/IM dosing in rats and dogs, with linear dose-proportional kinetics (PMID: 36588717); a 2026 biopharmaceutical review confirms this sub-30-minute plasma half-life and highlights a pharmacokinetic-pharmacodynamic disconnect, as biological effects persist for hours to days (PMID: 42198317). No full human pharmacokinetic study has been published; twice-daily dosing is empirical/community-standard rather than PK-derived.. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, Glow Blend or BPC-157?
Lowest listed price on BodyHackGuide: Glow Blend from $99.99, BPC-157 from $34.99. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack Glow Blend and BPC-157?
Stacking depends on mechanism overlap, safety profile, and goals. Glow Blend and BPC-157 should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Glow Blend or BPC-157
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.